4DMedical (formerly 4Dx) is a medical technology company based in Melbourne, Australia founded by ALHI Principal Investigator, Prof Andreas Fouras, PhD.  4DMedical’s FDA cleared and TGA approved XV Lung Ventilation Analysis Software platform is a world-first, providing a state-of-the-art, non-invasive way of understanding regional lung motion and airflow in real-time within the breathing lungs.  This enables highly detailed maps of patterns of lung motion and pulmonary function, with functional deficits detected through local differences in movement. The end result: improving millions of lives through earlier disease detection and more accurate monitoring of chronic respiratory conditions.